IRIS Accounts Production v25.1.4.42 01346342 Board of Directors 1.3.24 28.2.25 28.2.25 true false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh013463422024-02-29013463422025-02-28013463422024-03-012025-02-28013463422022-08-31013463422022-09-012024-02-29013463422024-02-2901346342ns15:EnglandWales2024-03-012025-02-2801346342ns14:PoundSterling2024-03-012025-02-2801346342ns10:Director12024-03-012025-02-2801346342ns10:PrivateLimitedCompanyLtd2024-03-012025-02-2801346342ns10:SmallEntities2024-03-012025-02-2801346342ns10:AuditExempt-NoAccountantsReport2024-03-012025-02-2801346342ns10:SmallCompaniesRegimeForDirectorsReport2024-03-012025-02-2801346342ns10:SmallCompaniesRegimeForAccounts2024-03-012025-02-2801346342ns10:FullAccounts2024-03-012025-02-2801346342ns10:Director22024-03-012025-02-2801346342ns10:Director42024-03-012025-02-2801346342ns10:Director52024-03-012025-02-2801346342ns10:Director62024-03-012025-02-2801346342ns10:RegisteredOffice2024-03-012025-02-2801346342ns5:CurrentFinancialInstruments2025-02-2801346342ns5:CurrentFinancialInstruments2024-02-2901346342ns5:Non-currentFinancialInstruments2025-02-2801346342ns5:Non-currentFinancialInstruments2024-02-2901346342ns5:ShareCapital2025-02-2801346342ns5:ShareCapital2024-02-2901346342ns5:RetainedEarningsAccumulatedLosses2025-02-2801346342ns5:RetainedEarningsAccumulatedLosses2024-02-2901346342ns5:LongLeaseholdAssetsns5:LandBuildings2024-03-012025-02-2801346342ns5:FurnitureFittings2024-03-012025-02-2801346342ns5:MotorVehicles2024-03-012025-02-2801346342ns5:LongLeaseholdAssetsns5:LandBuildings2024-02-2901346342ns5:FurnitureFittings2024-02-2901346342ns5:MotorVehicles2024-02-2901346342ns5:LongLeaseholdAssetsns5:LandBuildings2025-02-2801346342ns5:FurnitureFittings2025-02-2801346342ns5:MotorVehicles2025-02-2801346342ns5:LongLeaseholdAssetsns5:LandBuildings2024-02-2901346342ns5:FurnitureFittings2024-02-2901346342ns5:MotorVehicles2024-02-2901346342ns5:CostValuation2024-02-2901346342ns5:DisposalsRepaymentsInvestments2025-02-2801346342ns5:CostValuation2025-02-2801346342ns5:Subsidiary12024-03-012025-02-28013463421ns5:Subsidiary12024-03-012025-02-2801346342ns5:Subsidiary22024-03-012025-02-2801346342ns5:Subsidiary232024-03-012025-02-2801346342ns5:Subsidiary32024-03-012025-02-28013463425ns5:Subsidiary32024-03-012025-02-2801346342ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-2801346342ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-29
REGISTERED NUMBER: 01346342 (England and Wales)













Unaudited Financial Statements

for the Year Ended 28 February 2025

for

Coopers Chemist Marske Limited

Coopers Chemist Marske Limited (Registered number: 01346342)






Contents of the Financial Statements
for the Year Ended 28 February 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Coopers Chemist Marske Limited

Company Information
for the Year Ended 28 February 2025







DIRECTORS: P I Brady
Mrs L Cooper
Mrs J C Cooper
J Cooper
Dr D W Cooper





REGISTERED OFFICE: 112 High Street
Marske-By-The-Sea
Redcar
Cleveland
TS11 7BA





REGISTERED NUMBER: 01346342 (England and Wales)





ACCOUNTANTS: Anderson Barrowcliff Limited
Chartered Accountants
3 Kingfisher Court
Bowesfield Park
Stockton on Tees
TS18 3EX

Coopers Chemist Marske Limited (Registered number: 01346342)

Balance Sheet
28 February 2025

2025 2024
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 11,627 16,144
Investments 5 1,689,660 1,690,160
1,701,287 1,706,304

CURRENT ASSETS
Stocks 122,719 137,959
Debtors 6 248,409 271,556
Cash at bank and in hand 66,194 94,457
437,322 503,972
CREDITORS
Amounts falling due within one year 7 878,208 849,990
NET CURRENT LIABILITIES (440,886 ) (346,018 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,260,401

1,360,286

CREDITORS
Amounts falling due after more than one
year

8

(200,000

)

(200,000

)

PROVISIONS FOR LIABILITIES - (17,367 )
NET ASSETS 1,060,401 1,142,919

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,060,301 1,142,819
1,060,401 1,142,919

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Coopers Chemist Marske Limited (Registered number: 01346342)

Balance Sheet - continued
28 February 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 June 2025 and were signed on its behalf by:





J Cooper - Director


Coopers Chemist Marske Limited (Registered number: 01346342)

Notes to the Financial Statements
for the Year Ended 28 February 2025

1. STATUTORY INFORMATION

Coopers Chemist Marske Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about Coopers Chemist Marske Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - 10% on cost
Fixtures and fittings - 20% on cost
Motor vehicles - 25% on cost

Investments in subsidiaries
Investments in subsidiaries and associates are measured at cost less impairment.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Coopers Chemist Marske Limited (Registered number: 01346342)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2025

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Impairment
Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset's cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit and loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease,

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 30 (2024 - 32 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Long and Motor
leasehold fittings vehicles Totals
£    £    £    £   
COST
At 1 March 2024 94,351 262,107 10,580 367,038
Disposals - (192,064 ) (10,580 ) (202,644 )
At 28 February 2025 94,351 70,043 - 164,394
DEPRECIATION
At 1 March 2024 86,349 253,965 10,580 350,894
Charge for year 975 2,783 - 3,758
Eliminated on disposal - (191,305 ) (10,580 ) (201,885 )
At 28 February 2025 87,324 65,443 - 152,767
NET BOOK VALUE
At 28 February 2025 7,027 4,600 - 11,627
At 29 February 2024 8,002 8,142 - 16,144

5. FIXED ASSET INVESTMENTS
Shares in
group Other
undertakings investments Totals
£    £    £   
COST
At 1 March 2024 1,689,660 500 1,690,160
Disposals - (500 ) (500 )
At 28 February 2025 1,689,660 - 1,689,660
NET BOOK VALUE
At 28 February 2025 1,689,660 - 1,689,660
At 29 February 2024 1,689,660 500 1,690,160

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Coopers Chemist Gt Ayton Limited
Registered office: 112 High Street, Marske by The Sea, Redcar, TS11 7BA
Nature of business:
%
Class of shares: holding
Ordinary 50.00

Coopers Chemist Marske Limited (Registered number: 01346342)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2025

5. FIXED ASSET INVESTMENTS - continued

Coopers Chemist Redcar Limited
Registered office: 112 High Street, Marske by The Sea, Redcar, TS11 7BA
Nature of business:
%
Class of shares: holding
Ordinary 100.00

Park Avenue Pharmacy Limited
Registered office: 10 Park Avenue, Redcar, TS10 3JZ
Nature of business:
%
Class of shares: holding
Ordinary 100.00

The directors have carried out an impairment review of its investments in subsidiary companies, having taken professional advice over the valuation of pharmacy businesses under current market conditions.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 164,209 176,822
Amounts owed by group undertakings 82,362 90,713
Other debtors 1,838 4,021
248,409 271,556

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 208,078 275,264
Amounts owed to group undertakings 641,332 525,710
Taxation and social security 24,911 15,931
Other creditors 3,887 33,085
878,208 849,990

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Preference shares 200,000 200,000

9. OTHER FINANCIAL COMMITMENTS

The total amount of financial commitments not included in the accounts is £66,460 (2024 - £106,336)